Lifecare CEO Joacim Holter will presents the company's technology status anddevelopment at Redeye Diabetes Event 2023 on May 24 at 11:05 AM CEST.
The presentations are live broadcasted athttps://www.redeye.se/events/870294/redeye-theme-diabetes
ABOUT LIFECARELifecare AS is a clinical stage medical sensor company developing technology forsensing and monitoring of various body analytes. Lifecare's main focus is tobring the next generation of Continuous Glucose Monitoring ("CGM") systems tomarket. Lifecare enables osmotic pressure as sensing principle, combined withthe ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") onthe sensor body for read-out of pressure variations. LifecareŽs sensortechnology is referred to as "Sencell" and is suitable for identifying andmonitoring the occurrence of a wide range of analytes and molecules in the humanbody.
Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.attme.dev,+47 40 05 90 40
This stock exchange announcement was published by Joacim Holter, CEO at LifecareAS, on 22 May 2023 at 13:50 CET.